Technology Group Inc Genesis serves as Executive at Lotus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Technology Group Inc Genesis has executed 2 insider transactions totaling $374.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 6, 2007 involved selling 680,000 shares valued at $374.0K.
Technology Group Inc Genesis currently holds 5,399,206 shares of Lotus Pharmaceuticals, Inc. (LTUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Technology Group Inc Genesis has been a net seller of LTUS stock. They have purchased $0 and sold $374.0K worth of shares.
Technology Group Inc Genesis's most recent insider trade was on Aug 6, 2007, when they sold 680,000 shares at $0.55 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |